Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman

Tamoxifen is a well-established therapy of choice for breast cancer management. However, there are growing evidences indicate the emergence of tamoxifen resistances in treating the breast cancer. Aloe emodin (l,8-dihydroxy-3-hydroxymethyl-anthraquinone) is a herbal anthraquinone derivative of aloe v...

Full description

Saved in:

Bibliographic Details
Main Author:	Abang Othman, Dayang Zahidah
Format:	Thesis
Language:	English
Published:	2012
Subjects:	RC Internal Medicine
Online Access:	https://ir.uitm.edu.my/id/eprint/72175/1/72175.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-uitm-ir.72175
record_format	uketd_dc
spelling	my-uitm-ir.721752024-01-02T09:04:24Z Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman 2012 Abang Othman, Dayang Zahidah RC Internal Medicine Tamoxifen is a well-established therapy of choice for breast cancer management. However, there are growing evidences indicate the emergence of tamoxifen resistances in treating the breast cancer. Aloe emodin (l,8-dihydroxy-3-hydroxymethyl-anthraquinone) is a herbal anthraquinone derivative of aloe vera which has been suggested to induce apoptosis in cancer cells by efficiently limiting various tumour cell proliferation as well as restricting cancer growth without affecting the normal cells. Hence, the objectives of this study are to determine the threshold doses of aloe emodin and tamoxifen in the MCF7 breast cancer cells and to clarify the effect of aloe emodin, tamoxifen and combination of both treatments on the MCF7 breast cancer cells as compared to the MCFIOA normal breast cells using the threshold doses. Cell proliferation assay was initially conducted to determine the threshold doses of tamoxifen and aloe emodin on MCF7 cells. The threshold doses for MCFIOA cells have been determined earlier by other co-researcher in different project. There were three main treatments in this study: aloe emodin, tamoxifen or combination of both which were conducted in both MCF7 and MCFIOA cells. The Trypan blue exclusion assay was then conducted in time dependent manner after each treatment for the MCF7 and MCFIOA cells using the determined threshold doses. The viable cells were identified and counted at the end of 18, 24, 36 and 48 hours. 2012 Thesis https://ir.uitm.edu.my/id/eprint/72175/ https://ir.uitm.edu.my/id/eprint/72175/1/72175.pdf text en public degree Universiti Teknologi MARA (UiTM) Faculty of Medicine Siran, Rosfaiizah
institution	Universiti Teknologi MARA
collection	UiTM Institutional Repository
language	English
advisor	Siran, Rosfaiizah
topic	RC Internal Medicine
spellingShingle	RC Internal Medicine Abang Othman, Dayang Zahidah Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman
description	Tamoxifen is a well-established therapy of choice for breast cancer management. However, there are growing evidences indicate the emergence of tamoxifen resistances in treating the breast cancer. Aloe emodin (l,8-dihydroxy-3-hydroxymethyl-anthraquinone) is a herbal anthraquinone derivative of aloe vera which has been suggested to induce apoptosis in cancer cells by efficiently limiting various tumour cell proliferation as well as restricting cancer growth without affecting the normal cells. Hence, the objectives of this study are to determine the threshold doses of aloe emodin and tamoxifen in the MCF7 breast cancer cells and to clarify the effect of aloe emodin, tamoxifen and combination of both treatments on the MCF7 breast cancer cells as compared to the MCFIOA normal breast cells using the threshold doses. Cell proliferation assay was initially conducted to determine the threshold doses of tamoxifen and aloe emodin on MCF7 cells. The threshold doses for MCFIOA cells have been determined earlier by other co-researcher in different project. There were three main treatments in this study: aloe emodin, tamoxifen or combination of both which were conducted in both MCF7 and MCFIOA cells. The Trypan blue exclusion assay was then conducted in time dependent manner after each treatment for the MCF7 and MCFIOA cells using the determined threshold doses. The viable cells were identified and counted at the end of 18, 24, 36 and 48 hours.
format	Thesis
qualification_level	Bachelor degree
author	Abang Othman, Dayang Zahidah
author_facet	Abang Othman, Dayang Zahidah
author_sort	Abang Othman, Dayang Zahidah
title	Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman
title_short	Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman
title_full	Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman
title_fullStr	Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman
title_full_unstemmed	Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman
title_sort	aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / dayang zahidah abang othman
granting_institution	Universiti Teknologi MARA (UiTM)
granting_department	Faculty of Medicine
publishDate	2012
url	https://ir.uitm.edu.my/id/eprint/72175/1/72175.pdf
_version_	1794191888417292288

Aloe emodin as an agent to enhance the cytotoxic effects of tamoxifen in breast cancer cells / Dayang Zahidah Abang Othman

Similar Items